Statera Biopharma STAB Stock
Statera Biopharma Price Chart
Statera Biopharma STAB Financial and Trading Overview
| Statera Biopharma stock price | 0.0006 USD |
| Previous Close | 0.03 USD |
| Open | 0.04 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 3000 |
| Day's Range | 0.03 - 0.04 USD |
| 52 Week Range | 0.01 - 0.31 USD |
| Volume | 88.92K USD |
| Avg. Volume | 220.16K USD |
| Market Cap | 2.36M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.36 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
STAB Valuation Measures
| Enterprise Value | 8.83M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.63908565 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 2.395 |
| Enterprise Value/EBITDA | -0.429 |
Trading Information
Statera Biopharma Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -86.25% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.31 USD |
| 52 Week Low | 0.01 USD |
| 50-Day Moving Average | 0.02 USD |
| 200-Day Moving Average | 0.07 USD |
STAB Share Statistics
| Avg. Volume (3 month) | 220.16K USD |
| Avg. Daily Volume (10-Days) | 84.66K USD |
| Shares Outstanding | 71.42M |
| Float | 47.55M |
| Short Ratio | 0.39 |
| % Held by Insiders | 12.18% |
| % Held by Institutions | 3.47% |
| Shares Short | 774.54K |
| Short % of Float | 1.65% |
| Short % of Shares Outstanding | 1.41% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -573.26% |
| Gross Margin | 70.26% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -23.85% |
| Return on Equity (ttm) | -286.93% |
Income Statement
| Revenue (ttm) | 3.69M USD |
| Revenue Per Share (ttm) | 0.08 USD |
| Quarterly Revenue Growth (yoy) | 183.50% |
| Gross Profit (ttm) | 998.72K USD |
| EBITDA | -20583648 USD |
| Net Income Avi to Common (ttm) | -91832616 USD |
| Diluted EPS (ttm) | -2.35 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 506.1K USD |
| Total Cash Per Share (mrq) | 0.009 USD |
| Total Debt (mrq) | 7.41M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.055 |
| Book Value Per Share (mrq) | -0.202 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -12091082 USD |
| Levered Free Cash Flow (ttm) | 340.1K USD |
Profile of Statera Biopharma
| Country | United States |
| State | CO |
| City | Fort Collins |
| Address | 4333 Corbett Drive |
| ZIP | 80525 |
| Phone | 888 613 8802 |
| Website | https://www.staterabiopharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 46 |
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. It has clinical programs for Crohn's disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401), and COVID-19 (STAT-205), as well as fibromyalgia and multiple sclerosis. The company was formerly known as Cytocom, Inc. and changed its name to Statera Biopharma, Inc. in September 2021. Statera Biopharma, Inc. is based in Fort Collins, Colorado.
Q&A For Statera Biopharma Stock
What is a current STAB stock price?
Statera Biopharma STAB stock price today per share is 0.0006 USD.
How to purchase Statera Biopharma stock?
You can buy STAB shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Statera Biopharma?
The stock symbol or ticker of Statera Biopharma is STAB.
Which industry does the Statera Biopharma company belong to?
The Statera Biopharma industry is Biotechnology.
How many shares does Statera Biopharma have in circulation?
The max supply of Statera Biopharma shares is 71.42M.
What is Statera Biopharma Price to Earnings Ratio (PE Ratio)?
Statera Biopharma PE Ratio is now.
What was Statera Biopharma earnings per share over the trailing 12 months (TTM)?
Statera Biopharma EPS is -2.36 USD over the trailing 12 months.
Which sector does the Statera Biopharma company belong to?
The Statera Biopharma sector is Healthcare.
Statera Biopharma STAB included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}